Observational studyInternational journal of hematology2022

NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan.

Wen-Li Hwang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.